2008
DOI: 10.1074/jbc.m703758200
|View full text |Cite
|
Sign up to set email alerts
|

Eag1 and Bestrophin 1 Are Up-regulated in Fast-growing Colonic Cancer Cells

Abstract: An increasing number of studies demonstrate proliferative effects of membrane ion channels (1). Voltage-gated K ϩ channels and other types of K ϩ channels are expressed in numerous types of tumors, where they may serve as diagnostic and prognostic markers and potential drug targets (2-4). Eag1 channels are probably necessary for progression through the G 1 phase and G 0 /G 1 transition of the cell cycle (5). A recent study demonstrates the hyperpolarizing effects of Eag1 and other Kv channels on the membrane v… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
58
1
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 54 publications
(62 citation statements)
references
References 32 publications
2
58
1
1
Order By: Relevance
“…These results suggest that very effective suppression of Ano1 expression is necessary to eliminate the pro-proliferative effects of Ano1, suggesting that low expression of Ano1 is sufficient to induce this effect. While siRNA had no effect in HT 29 cells, 1 mM staurosporine (figure 1a black arrow, dashed lines) inhibited proliferation and induced cell apoptosis in colonic carcinoma cells, as demonstrated in an earlier publication [28]. Thus, enhanced expression of Ano1 does not seem to enhance proliferation in every cell type [27,29].…”
Section: Ano1 Is Located On the 11q13 Ampliconmentioning
confidence: 74%
See 1 more Smart Citation
“…These results suggest that very effective suppression of Ano1 expression is necessary to eliminate the pro-proliferative effects of Ano1, suggesting that low expression of Ano1 is sufficient to induce this effect. While siRNA had no effect in HT 29 cells, 1 mM staurosporine (figure 1a black arrow, dashed lines) inhibited proliferation and induced cell apoptosis in colonic carcinoma cells, as demonstrated in an earlier publication [28]. Thus, enhanced expression of Ano1 does not seem to enhance proliferation in every cell type [27,29].…”
Section: Ano1 Is Located On the 11q13 Ampliconmentioning
confidence: 74%
“…This inverse correlation between low Ano1 levels and upregulation of mTOR [51] suggests that Ano1 may be inhibitory on proliferation of mouse intestinal epithelial cells, similar to HT 29 cells. Interestingly, a fast growing subclone of T 84 colonic epithelial cells (T 84 fast) is lacking expression of Ano1, when compared with the slowly growing parental cells (T 84 slow) [28] ( figure 5a,b). Notably, treatment of fast growing T 84 cells with the mTOR-inhibitor rapamycin reduced proliferation and induced expression of Ano1 ( figure 5c,d).…”
Section: Ano1 Required For Terminal Differentiation?mentioning
confidence: 99%
“…From another mechanistic viewpoint, we have previously shown that the development of intestinal cancer is characterized by the expression of oncogenic K þ ion channels, such as voltage-gated K þ channels of the ether-a-go-go (Eag) family and large conductance Ca 2 þ -activated K þ channels Spitzner et al, 2007Spitzner et al, , 2008. Ion channels have been found to support the proliferation and development of cancer cells (Kunzelmann, 2005).…”
mentioning
confidence: 99%
“…It has been reported that APC Min/ þ mice show upregulated phosphoinositide-3 kinase-Akt signaling in intestinal tumors (Moran et al, 2004;Spitzner et al, 2008), which is a main route of triggering mTOR. Besides this quite direct involvement of mTOR in tumor formation in the gut, APC mutations have also been related to alterations in Wnt-Akt-b-catenin signaling, which is commonly dysregulated in colorectal cancers (Fodde et al, 2001;Dihlmann et al, 2005).…”
mentioning
confidence: 99%
“…Nevertheless, the related study in bestrophin-1 shows the protein improves intracellular Ca 2+ signaling and increases cell growth rate in colonic carcinoma cells. The proliferation of the cells is significantly suppressed by bestrophin-1 RNA interference treatment (Spitzner et al, 2008). This indicates bestrophin-3 may be a potential target for breast cancer therapy.…”
Section: Functional Classifications Of the Identified Breast Cancer Mmentioning
confidence: 64%